gliclazide brands
12 registered brands containing gliclazide in Botswana.
Gliclazide
PubChem CID 3475Molecular formula: C15H21N3O3S
Gliclazide binds to the β cell sulfonyl urea receptor (SUR1). This binding subsequently blocks the ATP sensitive potassium channels. The binding results in closure of the channels and leads to a resulting decrease in potassium efflux leads to depolarization of the β cells. This opens voltage-dependent calcium channels in the β cell resulting in calmodulin activation, which in turn leads to exocytosis of insulin containing secretorty granules.
Source: PubChem (NCBI) ยท compound 3475
All countries
Kenya
Tanzania
Rwanda
Zambia
Uganda
Malawi
South Africa
Zimbabwe
Nigeria
Ghana
Botswana
| Product | Manufacturer | Status | Country |
|---|---|---|---|
| DYNACAZ 60 MG MR Modified-release tablet |
Krka | Registered/Compliant | Botswana |
| DYNACAZ 60 MG MR Modified-release tablet |
Krka | Registered/Compliant | Botswana |
| DYNACAZ 60 MG MR Modified-release tablet |
Krka | Registered/Compliant | Botswana |
| DYNACAZ 60 MG MR Modified-release tablet |
Krka | Registered/Compliant | Botswana |
| DYNACAZ 60 MG MR Modified-release tablet |
Krka | Registered/Compliant | Botswana |
| DYNACAZ 90 MG MR Modified-release tablet |
Krka | Registered/Compliant | Botswana |
| DYNACAZ 90 MG MR Modified-release tablet |
Krka | Registered/Compliant | Botswana |
| DYNACAZ 90 MG MR Modified-release tablet |
Krka | Registered/Compliant | Botswana |
| DYNACAZ 90 MG MR Modified-release tablet |
Krka | Registered/Compliant | Botswana |
| DYNACAZ 90 MG MR Modified-release tablet |
Krka | Registered/Compliant | Botswana |
| ZIGLIC MR 30 Modified-release tablet |
Inventia Healthcare | Registered/Compliant | Botswana |
| ZIGLIC MR 60 Modified-release tablets |
Inventia Healthcare | Registered/Compliant | Botswana |